Are Analysts Expecting A Better 2020 For RxSight Inc (RXST)?

RxSight Inc (RXST) concluded trading on Thursday at a closing price of $51.58, with 0.38 million shares of worth about $19.58 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 87.09% during that period and on March 28, 2024 the price saw a gain of about 1.80%. Currently the company’s common shares owned by public are about 36.14M shares, out of which, 30.88M shares are available for trading.

However, the stock later moved at a day high price of 51.96, or with a gain of 1.80%. Stock saw a price change of 0.90% in past 5 days and over the past one month there was a price change of -8.53%. Year-to-date (YTD), RXST shares are showing a performance of 27.93% which increased to 215.86% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $16.15 but also hit the highest price of $58.21 during that period. The average intraday trading volume for RxSight Inc shares is 462.94K. The stock is currently trading 1.43% above its 20-day simple moving average (SMA20), while that difference is up 2.29% for SMA50 and it goes to 46.57% higher than SMA200.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

RxSight Inc (NASDAQ: RXST) currently have 36.14M outstanding shares and institutions hold larger chunk of about 78.88% of that.

The stock has a current market capitalization of $1.91B and its 3Y-monthly beta is at 1.21. It has posted earnings per share of -$1.42 in the same period. It has Quick Ratio of 7.22 while making debt-to-equity ratio of 0.02. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for RXST, volatility over the week remained 4.26% while standing at 5.14% over the month.

Analysts are in expectations that RxSight Inc (RXST) stock would likely to be making an EPS of -$0.27 in the current quarter, while forecast for next quarter EPS is -$0.24 and it is -$0.71 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.32 which is -$0.07 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.42 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 30.33% while it is estimated to increase by 27.58% in next year.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Wells Fargo on December 13, 2023 offering an Overweight rating for the stock and assigned a target price range of between $31 and $42 to it. Coverage by Stifel stated RxSight Inc (RXST) stock as a Buy in their note to investors on December 12, 2023, suggesting a price target of $40 for the stock. On December 04, 2023, Morgan Stanley Initiated their recommendations, while on April 13, 2023, Oppenheimer Initiated their ratings for the stock with a price target of $23. Stock get an Equal weight rating from Wells Fargo on December 12, 2022.

Most Popular

Related Posts